Logo

American Heart Association

  2
  0


Final ID: Sa2186

Association of histologic findings with long-term outcomes in symptomatic obstructive hypertrophic cardiomyopathy patients undergoing surgical myectomy

Abstract Body (Do not enter title and authors here): Background: In hypertrophic cardiomyopathy (HCM), histologic findings like myocyte hypertrophy & disarray, interstitial fibrosis (IF) & small intramural coronary arteriole dysplasia (SICAD) account for the left ventricular hypertrophy, diastolic dysfunction, arrhythmogenicity & microvascular ischemia.
Objectives: To evaluate the association between histology & outcomes in obstructive HCM (oHCM) patients undergoing surgical myectomy (SM).
Methods: This was an observational study of 1722 symptomatic oHCM patients (mean age 56±14 years, 948 [55%] men) who underwent SM at a tertiary care center between 2005-18. Baseline clinical data was collected. The SM specimen was analyzed for presence & severity of a) myocyte hypertrophy b) myocyte disarray c) IF & d) SICAD. Histologic findings were graded as 0-3 (none, mild, moderate, & severe) & a score from 0-12 was calculated. Primary endpoint was a composite of death, appropriate defibrillator discharge or cardiac transplantation during follow-up.
Results: 896 (52%) were in New York Heart Association (NYHA) class III/IV, 457 (21%) had exertional syncope, 727 (42%) had ≥1 sudden death risk factor & 409 (24%) had atrial fibrillation (AF). Moderate & severe histologic findings were distributed as follows: myocyte hypertrophy (1341 [78%]), disarray (237 [14%]), IF (448 [26%]) & SICAD (258 [15%]). The mean total histologic score was 5.1±1.4. At 5.1±5.2 years, there were 352 (20%) primary events (317 [18%] deaths). On spline analysis (Figure 1A), a total histology score of ≥ 6 was associated with primary events. On Kaplan-Meier analysis (Figure 1B), patients with a histology score ≥ 6 had greater events vs. those with a score <6 (147/598 [25%] vs. 205/1124 [18%], log-rank p-value 0.002). On multivariable Cox analysis, age (for 10-year increase, Hazard ratio or HR 1.49 [95% confidence interval or CI 1.35-1.65], p<0.001), NYHA Class III/IV (HR 1.58 [95% CI -1.25-2.01], p<0.001), AF (HR 1.65 [95% CI 1.30-2.10], p<0.001) & histology score ≥6 (HR 1.24 [95% CI 1.03-1.54], p=0.03) were independently associated with higher primary events.
Conclusions: In symptomatic oHCM patients undergoing SM, a higher histologic score was independently associated with long-term outcomes.
  • Jadam, Shada  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Popovic, Zoran  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Desai, Milind  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Gaballa, Andrew  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Alashi, Alaa  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Xu, Bo  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Thamilarasan, Maran  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Rodriguez, E  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Tan, Carmela  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Ospina, Susan  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Smedira, Nicholas  ( Cleveland Clinic Foundation , Cleveland , Ohio , United States )
  • Author Disclosures:
    Shada Jadam: DO NOT have relevant financial relationships | Zoran Popovic: DO NOT have relevant financial relationships | Milind Desai: DO have relevant financial relationships ; Consultant:Bristol Myers Squibb:Active (exists now) ; Consultant:Cytokinetics:Active (exists now) ; Consultant:Edgewise:Active (exists now) ; Consultant:Viz AI:Active (exists now) ; Consultant:Tenaya:Active (exists now) | Andrew Gaballa: DO NOT have relevant financial relationships | Alaa Alashi: DO NOT have relevant financial relationships | Bo Xu: DO have relevant financial relationships ; Speaker:Bristol Myers Squibb:Active (exists now) | Maran Thamilarasan: DO NOT have relevant financial relationships | E Rodriguez: DO NOT have relevant financial relationships | Carmela Tan: DO NOT have relevant financial relationships | Susan Ospina: DO have relevant financial relationships ; Speaker:Bristol Myers Squibb:Active (exists now) | Nicholas Smedira: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Cardiomyopathy Potpourri 1

Saturday, 11/16/2024 , 02:00PM - 03:00PM

Abstract Poster Session

More abstracts on this topic:
A Case of Hypertrophic Cardimyopathy: Digenic Variants of Uncertain Significance Mutations in MHY7 and RYR2 Genes

Durukan Selina, Uzunoglu Ekin, Farahmandsadr Maryam, Soffer Daniel

Association of Sociodemographic Characteristics on Costs of Care in Patients with Obstructive Hypertrophic Cardiomyopathy

Reza Nosheen, Butzner Michael, Batra Kirti, Amos Qiana, Buikema Ami, Anderson Amy, Shreay Sanatan, Owens Anjali

More abstracts from these authors:
Outcomes of Patients with Radiation-Associated Cardiac Disease Undergoing Cardiothoracic Surgery: Development of a Disease Specific Risk Score

Gaballa Andrew, Griffin Brian, Desai Milind, Jadam Shada, Wang Tom Kai Ming, Unai Shinya, Koprivanic Marijan, Roselli Eric, Xu Samantha, Ospina Susan, Collier Patrick

Mavacamten Treatment in Patients with Obstructive HCM Referred for Septal Reduction Therapy: 128-Week Results from VALOR-HCM Trial

Desai Milind, Nissen Steven

You have to be authorized to contact abstract author. Please, Login
Not Available